ANTALGENTA
ItalyIt is used to treat inflammatory forms of the skin caused by bacteria, such as pyodermas, folliculitis, boils, acne, and pustular psoriasis. It is also useful for traumatic lesions, burns, infected excoriations, and for bacterial superinfections that occur alongside infections caused by fungi or viruses.
Frequently asked questions
How should ANTALGENTA 0,1% cream be applied?
The cream should be applied 3-4 times a day until initial results are obtained; subsequently, applications can be reduced to 1-2 times within 24 hours. After application, it is advisable to protect the area with a sterile gauze.
What are the side effects of ANTALGENTA 0,1% cream?
Treatment may cause temporary irritation, such as redness (erythema) or itching, which usually does not require discontinuation of the treatment. However, prolonged use may cause sensitization phenomena or local skin reactions such as contact dermatitis.
When should this medicine not be used?
It must not be used in case of hypersensitivity to the active ingredient (gentamicin), to other chemically related substances, or to any of the excipients. The product cannot be used for ocular use.
Are there any special precautions to follow?
In case of sensitization, it is necessary to discontinue treatment and start appropriate therapy. As it is an antibiotic, use may promote the growth of resistant microorganisms. In case of pregnancy or in very early childhood, the product should be used only if strictly necessary and under direct medical supervision.
Can the product cause allergies?
Yes, the product contains chlorocresol, which can cause allergic reactions, and cetostearyl alcohol, which can cause local skin reactions such as contact dermatitis.
Instructions for use
Table of contents
PACKAGE LEAFLET
ANTALGENTA 0.1% cream
Generic medicine
COMPOSITION
100 g of cream contain:
Active substance: gentamicin 0.1 g (as gentamicin sulfate 0.166 g)
Excipients: Cetostearyl alcohol, cetomacrogol, white soft paraffin, liquid paraffin, monobasic sodium phosphate, chlorocresol, purified water.
PHARMACEUTICAL FORM AND CONTENT
Cream. 30 g tube.
THERAPEUTIC PHARMACOLOGICAL CATEGORY
Antibiotics and chemotherapeutic agents for dermatological use.
MARKETING AUTHORISATION HOLDER
SF GROUP Srl – via Tiburtina 1143, 00156 Rome (Italy)
MANUFACTURER AND FINAL CONTROLLER
LACHIFARMA Srl - SS 16 Zona Industriale, Zollino (Lecce)
THERAPEUTIC INDICATIONS
Bacterial skin inflammatory conditions, such as pyodermitis of varying severity and extent, including ecthyma, folliculitis, sycosis, furunculosis, microbial eczema, as well as secondarily infected conditions such as impetiginized dermatitis and eczema, stasis ulcers, traumatic wounds, burns and infected excoriations.
Other skin conditions that benefit from the application of gentamicin include acne and pustular psoriasis, intertriginous lesions and bacterial perionyxitis.
Gentamicin is ineffective against fungal infections, since it has no activity against any fungal strains; however, the drug is useful in treating bacterial superinfections of fungal or viral infections.
Particular efficacy of the preparation has been demonstrated in burns of various degrees and extent, where the "devitalization of the tissue" caused by the intense thermal injury promotes the development of particularly virulent bacterial flora.
CONTRAINDICATIONS
Hypersensitivity to the active substance (gentamicin), to substances closely related from a chemical standpoint, or to any of the excipients.
PRECAUTIONS FOR USE
Prolonged use, especially, of topical products may lead to sensitization phenomena. In such cases, treatment must be discontinued and appropriate therapy initiated.
This preparation must not be used for ophthalmic purposes. As with all antibiotics, treatment with gentamicin may lead to overgrowth of insensitive microorganisms; in such cases, treatment must be suspended and appropriate therapy initiated. Cross-allergenicity among aminoglycosides has been demonstrated.
INTERACTIONS
None known so far.
SPECIAL WARNINGS
The product contains chlorocresol, which may cause allergic reactions.
The product also contains cetostearyl alcohol, which may cause local skin reactions such as contact dermatitis.
PREGNANCY AND BREAST-FEEDING
In pregnant women and in early infancy, the product should be administered only when strictly necessary and under direct medical supervision.
KEEP THIS MEDICINE OUT OF THE SIGHT AND REACH OF CHILDREN
DOSAGE, METHOD AND DURATION OF ADMINISTRATION
Apply the cream 3–4 times daily until initial improvement is observed; thereafter, the number of applications may be reduced to 1–2 times per day. After application, it is advisable to protect the treated area with sterile gauze.
OVERDOSE
No cases of overdose have been reported.
UNDESIRABLE EFFECTS
Treatment with gentamicin may occasionally cause transient irritation (erythema or pruritus), which usually does not require discontinuation of therapy. In such cases, subsequent patch testing has not demonstrated irritation or sensitization phenomena.
Following the instructions provided in this leaflet reduces the risk of adverse effects.
Patients should inform their physician or pharmacist of any adverse effects observed.
EXPIRY DATE AND STORAGE
See the expiry date stated on the packaging. This date refers to the product stored unopened and correctly preserved.
Warning: do not use the medicine after the expiry date stated on the packaging.
REVISION OF THE PACKAGE LEAFLET BY THE ITALIAN MEDICINES AGENCY: March 2015
Similar drugs
| Brand name | Dosage form | Active substance / Dosage | Manufacturer |
|---|---|---|---|
| EUTOPIC | cream | LABORATORIO FARMACOLOGICO MILANESE S.R.L. | |
| GENTALYN | cream | ORGANON ITALIA S.R.L. | |
| GENTAMICIN ALMUS | cream | ALMUS S.R.L. | |
| GENTAMICIN ALTER | cream | LABORATORI ALTER S.R.L. | |
| GENTAMICIN AUROBINDO | cream | AUROBINDO PHARMA (ITALIA) S.R.L. | |
| GENTAMICIN DOC GENERICI | cream | DOC GENERICI SRL | |
| GENTAMICIN EG | cream | EG S.P.A. | |
| GENTAMICIN HEXAL | cream | SANDOZ S.P.A. | |
| GENTAMICIN IDI | cream | IDI FARMACEUTICI S.R.L. | |
| GENTAMICIN MYLAN GENERICS | cream | MYLAN S.P.A. | |
| GENTAMICIN PENSA | cream | TOWA PHARMACEUTICAL S.P.A. | |
| GENTAMICIN TEVA | cream | TEVA ITALIA S.R.L. |
The original data is available in the language of the country of manufacture.
Data source: Italian Medicines Agency (AIFA)
Data last verified: September 21, 2026